FDA Announces Approval of OMB for Abbreviated New Drug Application Regulations

Summary

The Food and Drug Administration (FDA) is announcing that a collection of information entitled 'Abbreviated New Drug Application Regulations; Patent and Exclusivity Provisions' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995, as mandated by the U.S. government.